Hangzhou AGS Medtech Co Ltd Ordinary Shares - Class A 688581
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 78.15
- Day Range
- CNY 77.70–79.39
- 52-Week Range
- CNY 60.09–137.59
- Bid/Ask
- CNY 78.38 / CNY 78.39
- Market Cap
- CNY 4.54 Bil
- Volume/Avg
- 991,331 / —
Key Statistics
- Price/Earnings (Normalized)
- 17.96
- Price/Sales
- 8.21
- Dividend Yield (Trailing)
- 0.97%
- Dividend Yield (Forward)
- 0.97%
- Total Yield
- 0.97%
Company Profile
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 592
- Website
- http://www.bioags.com
Comparables
Valuation
|
Metric
|
688581
|
603301
|
688351
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.96 | 7.73 | — |
Price/Book Value | 2.02 | 1.00 | 6.94 |
Price/Sales | 8.21 | 1.07 | 35.49 |
Price/Cash Flow | 19.34 | 4.58 | 576.45 |
Price/Earnings
688581
603301
688351
Financial Strength
|
Metric
|
688581
|
603301
|
688351
|
|---|---|---|---|
Quick Ratio | 24.40 | 1.50 | 14.41 |
Current Ratio | 25.06 | 2.21 | 15.75 |
Interest Coverage | — | 24.52 | 0.04 |
Quick Ratio
688581
603301
688351
Profitability
|
Metric
|
688581
|
603301
|
688351
|
|---|---|---|---|
Return on Assets (Normalized) | — | 6.78% | — |
Return on Equity (Normalized) | — | 9.61% | — |
Return on Invested Capital (Normalized) | — | 8.71% | — |
Return on Assets
688581
603301
688351
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pjfqqpfx | Nbppnb | $185.4 Bil | |
SYK
| Stryker Corp | Ssxlwffthg | Njqf | $127.7 Bil | |
BSX
| Boston Scientific Corp | Rzskvtps | Gkplb | $107.6 Bil | |
MDT
| Medtronic PLC | Cpmltbs | Ywhlj | $105.9 Bil | |
DXCM
| DexCom Inc | Mqhswngqt | Qzjz | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Tygghzndxb | Jqcqvl | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Srjnqhlwb | Cdrt | $24.6 Bil | |
ALGN
| Align Technology Inc | Mnpmxnk | Gbztg | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Twvlpfltw | Qxnwws | $18.7 Bil | |
PODD
| Insulet Corp | Bkxclfzgn | Wyscm | $11.6 Bil |